Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 10 of 10 for “"DNAJB1-PRKACA"”.

  1. RNA Therapeutics for Fibrolamellar Hepatocellular Carcinoma

    … by a recurrent fusion of the heat shock protein DNAJB1 and the catalytic subunit of protein kinase A (PRKACA). Due to limited efficacy of conventional treatments such as chemotherapy and radiation my work explored new therapeutic options. As DNAJB1::PRKACA is known to initiate tumorigenesis, I …

    rockefeller Repository record for RNA Therapeutics for Fibrolamellar Hepatocellular Carcinoma (opens in a new tab)

  2. Substrate Identification of an Oncogenic Kinase: Elucidating the Pathogenesis of a Rare Liver Cancer

    … a new fusion gene in this cancer called DNAJB1-PRKACA that results from a break and re-fusion in chromosome 19. This chimeric gene results in a fusion kinase that acts as the driver of this cancer. While we have shown that the kinase activity of the fusion protein is essential for …

    rockefeller Repository record for Substrate Identification of an Oncogenic Kinase: Elucidating the Pathogenesis of a Rare Liver Cancer (opens in a new tab)

  3. FUNCTIONAL EXAMINATION OF LONG NONCODING RNAS AND RNA THERAPY IN FIBROLAMELLAR CARCINOMA

    … The majority of FLC patients harbor the hallmark DNAJB1-PRKACA (DP fusion), which is sufficient for tumor initiation and progression. Despite significant efforts toward drug discovery, including small molecule inhibitors of the DP chimeric protein, FLC therapies are not yet developed. Moreover, …

    cornell Repository record for FUNCTIONAL EXAMINATION OF LONG NONCODING RNAS AND RNA THERAPY IN FIBROLAMELLAR CARCINOMA (opens in a new tab)

  4. Multiomics for Elucidating the Pathogenesis of Liver Cancers: a Transcriptomic Signature of Fibrolamellar Hepatocellular Carcinoma

    … 19p13.12, producing the chimeric transcript DNAJB1::PRKACA, which is sufficient to drive FLC in mice. Nevertheless, a few cases of liver tumors presenting FLC histopathological characteristics but missing the chimera DNAJB1::PRKACA have been reported. They have either 1) a lack of protein …

    rockefeller Repository record for Multiomics for Elucidating the Pathogenesis of Liver Cancers: a Transcriptomic Signature of Fibrolamellar Hepatocellular Carcinoma (opens in a new tab)

  5. Investigating Genes Associated with Oncogenic PKA Activity in Fibrolamellar Carcinoma

    … All clinical cases of FLC contain a specific DNAJB1-PRKACA fusion. The mutation produces an oncogenic form of Protein Kinase A (PKA), known as DNAJ-PKAc, with enhanced binding activity compared to wild-type PKA. Specifically, DNAJ-PKAc interacts with different substrates than wild type PKA, …

    usfca Repository record for Investigating Genes Associated with Oncogenic PKA Activity in Fibrolamellar Carcinoma (opens in a new tab)

  6. Proteomic Analysis of WNT Signaling and Metabolism of Fibrolamellar Hepatocellular Carcinoma

    … response. Our lab has identified a fusion gene DNAJB1::PRKACA that is found in almost all FLC tumor samples sequenced to date. The fusion gene when expressed in mouse liver is sufficient to generate FLC, and elimination of the fusion transcript kills human tumors. The fusion results from a …

    rockefeller Repository record for Proteomic Analysis of WNT Signaling and Metabolism of Fibrolamellar Hepatocellular Carcinoma (opens in a new tab)

  7. TARGETING AND MONITORING OF AN “UNDRUGGABLE” DRIVER OF FIBROLAMELLAR HCC

    … to poor outcomes. FLC is driven by the DNAJB1-PRKACA fusion encoding the chimeric kinase DNAJ-PKAc, but direct inhibition of PKA is not clinically feasible. Methods: We engineered a syngeneic murine model (TIBxDNAJ-PKAc) and integrated metabolomics, transcriptomics, and immune profiling …

    jhu Repository record for TARGETING AND MONITORING OF AN “UNDRUGGABLE” DRIVER OF FIBROLAMELLAR HCC (opens in a new tab) Embargoed until 2027-05-01

  8. SINGLE-NUCLEUS MULTI-OMIC INVESTIGATIONS RESOLVE AND IDENTIFY NOVEL FEATURES OF FIBROLAMELLAR CARCINOMA

    … This deletion results in the chimeric protein DNAJB1-PRKACA (DP), which is sufficient for tumor initiation and progression and necessary for tumor maintenance. Research into pharmacological or siRNA suppression of DP is ongoing. However, due to off-target effects on wild-type PKA, it is …

    cornell Repository record for SINGLE-NUCLEUS MULTI-OMIC INVESTIGATIONS RESOLVE AND IDENTIFY NOVEL FEATURES OF FIBROLAMELLAR CARCINOMA (opens in a new tab)

  9. MULTI-OMIC INVESTIGATIONS INDENTIFY MICRO-RNA REGULATORS OF CELL PROLIFERATION AND REVEAL PROTEOGLYCAN ABERRANCY IN FIBROLAMELLAR CARCINOMA

    … 19 resulting in the fusion of the first exon of DNAJB1 with exons 2-10 of PRKACA. The resulting chimera gene, DNAJB1-PRKACA (DP), is found in >80% of FLC patients and is oncogenic in mice. Pharmacological inhibition of DP is an attractive therapeutic avenue, but inhibitors designed thus far are …

    cornell Repository record for MULTI-OMIC INVESTIGATIONS INDENTIFY MICRO-RNA REGULATORS OF CELL PROLIFERATION AND REVEAL PROTEOGLYCAN ABERRANCY IN FIBROLAMELLAR CARCINOMA (opens in a new tab)

  10. DEFINING THE METABOLIC LANDSCAPE OF FIBROLAMELLAR CARCINOMA

    … in-frame fusion of parts of two genes, DNAJB1 (DnaJ Heat Shock Protein Family Member B1) and PRKACA (Protein Kinase CAMP-Activated Catalytic subunit Alpha). Two landmark mouse studies demonstrated that DP is sufficient to drive tumorigenesis, and DP has been detected in the vast majority …

    cornell Repository record for DEFINING THE METABOLIC LANDSCAPE OF FIBROLAMELLAR CARCINOMA (opens in a new tab)